Belize vs Kyrgyzstan: Access to anti-retroviral drugs, male
Belize
48.0%
in 2024
Kyrgyzstan
48.0%
in 2024
Belize rank
120th
Kyrgyzstan rank
120th
Access to anti-retroviral drugs, male over time
- Belize
- Kyrgyzstan
How they compare
Belize currently reports 48.0% against 48.0% in Kyrgyzstan, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Kyrgyzstan ahead.
Belize ranks 120th and Kyrgyzstan ranks 120th of 141 countries.
Across the 3 decades both report, Belize averaged higher in 2 and Kyrgyzstan in 1.
Head to head by decade
| Decade | Belize | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.9% | 1.8% | 7.1% | Belize |
| 2010s | 30.8% | 18.8% | 12.0% | Belize |
| 2020s | 42.2% | 42.8% | 0.6% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Belize or Kyrgyzstan?
- Belize, at 48.0% against 48.0% in Kyrgyzstan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Belize and Kyrgyzstan?
- 0.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Kyrgyzstan?
- 25 years are reported by both, from 2000 to 2024.
- How do Belize and Kyrgyzstan rank globally for access to anti-retroviral drugs, male?
- Belize ranks 120th and Kyrgyzstan ranks 120th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.